About 15 results found for searched term "IDO-IN-1" (0.053 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2568 | IDO-IN-2 (NLG-919 Analogue) | IDO |
| GDC-0919 analogue | ||
| NLG919 is a potent IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor with Ki/EC50 of 7 nM/75 nM. | ||
| M8944 | IDO-IN-1 | IDO |
| IDO-IN-1 is a potent and selective indoleamine-2,3-dioxygenase (IDO) inhibitor with IC50 of 59 nM. | ||
| M9180 | Pyridostatin Trifluoroacetate Salt | DNA/RNA Synthesis |
| Pyridostatin TFA salt; PDS; CAS# 1085412-37-8(free base) | ||
| Pyridostatin Trifluoroacetate Salt is a G-quadruplexe stabilizer, with a Kd of 490 nM. | ||
| M9729 | diABZI (tautomerism) | STING |
| Diamidobenzimidazole STING Agonist-1 (tautomerism) | ||
| diABZI (STING agonist 1; Tautomerism) is a selective stimulator of interferon genes (STING) receptor agonist, with EC50s of 130, 186 nM for human and mouse, respectively. | ||
| M11332 | diABZI trihydrochloride | STING |
| Diamidobenzimidazole STING Agonist-1 3HCl | ||
| diABZI (STING agonist-1) trihydrochloride is a selective agonist of interferon gene-stimulated receptor (STING), with EC50 scores of 130 nM and 186 nM in mice and humans, respectively. | ||
| M11556 | NLG-919 (Navoximod) | IDO |
| Navoximod; GDC-0919; IDO-IN-7; NLG-1488 | ||
| Navoximod (GDC-0919; Nlg-919) is an effective IDO (indoleamine-(2,3)-dioxygenase) inhibitor with Ki/EC50 of 7 nM/75 nM respectively. | ||
| M14123 | diABZI | STING |
| Diamidobenzimidazole STING Agonist-1 | ||
| diABZI (Diamidobenzimidazole STING Agonist-1) is a selective stimulator of interferon genes (STING) receptor agonist, with EC50s of 130, 186 nM for human and mouse, respectively. | ||
| M29484 | IDO-IN-13 | IDO |
| IDO-IN-13 is a potent indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor with an EC50 of 17 nM, extracted from patent WO2019040102A1, example 43. | ||
| M30207 | 1-Acetyl-β-carboline | Others |
| 1-(9H-pyrido[3,4-b]indol-1-yl)ethanone | ||
| 1-Acetyl-β-carboline is metabolite of Nonomuraea endophytica. | ||
| M42450 | IDO1-IN-21 | IDO |
| IDO1-IN-21 is an IDO1 inhibitor (IC50 = 0.64 μM). | ||
| M42451 | IDO-IN-18 | IDO |
| IDO-IN-18 is an IDO inhibitor. | ||
| M57096 | Thalidomide-Piperazine-PEG1-NH2 | E3 Ligase Ligand-Linker Conjugates |
| Thalidomide-Piperazine-PEG1-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology. | ||
| M56704 | IDO1/2-IN-1 | IDO |
| IDO1/2-IN-1 is the first potent IDO1/IDO2 dual inhibitor with IC50s of 28 nM and 144 nM for IDO1 and IDO2, respectively. | ||
| M56703 | IDO1/2-IN-1 hydrochloride | IDO |
| IDO1/2-IN-1 hydrochloride is the first potent IDO1/IDO2 dual inhibitor with IC50s of 28 nM and 144 nM for IDO1 and IDO2, respectively. | ||
| M58329 | IDO2-IN-1 | IDO |
| IDO2-IN-1 is an orally active and potent Indoleamine 2,3-dioxygenase 2 (IDO2) inhibitor with an IC50 value of 112 nM. IDO2-IN-1 can be used for the research of inflammatory autoimmunity. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
